RA: How sustainable is DMARD-free remission?

Remission is achievable but many patients will have flares during tapering, rheumatologists say

Up to 20% of patients with early rheumatoid arthritis (RA) deemed suitable for tapering are likely to achieve sustained drug-free remission for a year or longer, a systematic review has found.

arthritic hands opening a pill bottle

Dutch researchers examined 51 studies reporting DMARD-free remission in people with RA, concentrating on seven they judged as high quality (five clinical trials and two observational cohort studies).

Therapies included biologics such as abatacept, tocilizumab, TNF